Precision BioSciences Inc (DTIL)

[swampboots]

DTIL:

DTIL: CART-T gene editing laboriously explained in this 2 hour video.

Explains why so complicated and expensive, and perhaps a firewall against competitors?

CART-T versus Crisper, a vocabular of the differences are explored and elaborated, ie. the reduction in unintended events.

The transformative aspect as well as this editing platform
theoretically scalability for 7K diseases are shockingly cogently difficult to comprehend as its value would be above the billions, and hit the big T if ideal outcomes are not compromised, for most unmet disease outcomes..